文献速递皮肤肿瘤

一年内转诊皮肤科中心就诊的原发性皮肤淋巴瘤患者:单中心观察性回顾性队列研究,涉及诊断与分期、合并症与相关症状、治疗实施与临床病程

Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2022-08-26

该单中心观察性回顾性队列研究纳入2019年1月1日至2019年12月31日在都灵大学皮肤科连续就诊的384例原发性皮肤淋巴瘤患者,随访更新至2020年12月。主要采用皮肤导向治疗(局部激素65.6%、光疗50.2%),39.3%患者病程中达完全缓解;瘙痒、合并症及高级别转化与未达完全缓解相关,而MF IA期与更易达完全缓解相关。

要点

  • 384例中CTCL 247例(64.3%),CBCL 137例(35.7%),最常见亚型为MF(48.4%)。
  • 62.3%的CTCL患者至少有一种合并症,其中心血管合并症占28.7%,20.2%有其他非皮肤肿瘤。
  • 39.3%患者病程中达完全缓解;瘙痒、合并症、高级别转化为未达CR相关因素,MF IA期与更易达CR相关。

核心结论

  • Th2细胞因子相关的瘙痒发生可能解释治疗抵抗增加,而相关合并症的存在可能减少治疗选择并降低治疗依从性。

研究设计与样本

  • 单中心观察性回顾性队列研究,连续纳入2019年1月1日至2019年12月31日在都灵大学皮肤科就诊的384例原发性皮肤淋巴瘤患者,随访更新至2020年12月。

主要发现

  • 247例为皮肤T细胞淋巴瘤(CTCL,64.3%),137例为皮肤B细胞淋巴瘤(CBCL,35.7%),最常见亚型为MF(48.4%)。
  • 62.3%的CTCL患者至少有一种合并症,主要为心血管合并症(28.7%),20.2%有其他非皮肤肿瘤。
  • 主要治疗方式为皮肤导向治疗:局部激素65.6%,光疗50.2%。
  • 39.3%患者在病程中达到完全缓解(CR)。
  • 瘙痒、合并症存在及高级别转化是与未达CR相关的因素,而MF IA期与更易达CR相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Primary cutaneous lymphomas (PCL) are rare diseases, but the indolent course makes their prevalence high. Although there are many treatment options, no hierarchy is recommended. OBJECTIVE: To identify the burden of PCL and describe clinical-pathologic features; associated comorbidities; analyse treatment approaches in real-life and the parameters associated with the achievement of complete response (CR). DESIGN, SETTING AND PARTICIPANTS: In this study, all the PCL patients (384 patients) consecutively seen at the Dermatologic Clinic of the University of Turin from January 1, 2019 to December 31, 2019, with follow-up updated to December 2020, were included. MAIN OUTCOMES AND MEASURES: Subtype of PCL, demographic data, time elapsed between first lesions and diagnosis, associated symptoms, comorbidities, staging at diagnosis, high-grade transformation, blood involvement, stage progression, therapies used and response were assessed. RESULTS: 247 were cutaneous T-cell lymphomas (CTCL, 64.3%), 137 cutaneous B-cell lymphomas (CBCL, 35.7%) and the most frequent subtype was MF (48.4%). 62.3% of CTCL patients showed at least one comorbidity, mainly cardiovascular (28.7%), 20.2% show other not cutaneous neoplasms. The main approaches were skin-directed therapies (topical steroids 65.6%; phototherapy 50.2%). 39.3% patients achieved a CR during the disease course. Pruritus, the presence of comorbidities and high-grade transformation were factors associated with failure to achieve CR, whereas stage IA of MF was associated with greater achievement of CR. CONCLUSIONS AND RELEVANCE: The Th2 cytokine related development of pruritus could justify increased resistance to treatment, while the presence of associated comorbidities could reduce treatment options as well as treatment compliance.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Macagno N, Mastorino L, Rubatto M, et al. Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course. J Eur Acad Dermatol Venereol. 2022. PMID: 35881645. doi:10.1111/jdv.18469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。